Status: Recruiting
DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors
To evaluate the safety and efficacy of DCSZ11 in combination with standard therapy in patients with advanced or metastatic solid tumors.
Participants needed: 9
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: West China HospitalUpdated: Mar 11, 2026Locations: 1
Eligibility criteria
Male or female patients aged ≥18 years. [+22]
Systemic anticancer therapy or investigational products within 6 months prior to... [+15]